Editorial: Combination strategies in the treatment of Melanoma by Paolo Antonio eAscierto

Subjects: “…Angiogenesis Inhibitors…”
Get full text

Dual Targeting of VEGFR2 and C‑Met Kinases via the Design and Synthesis of Substituted 3‑(Triazolo-thiadiazin-3-yl)indolin-2-one Derivatives as Angiogenesis Inhibitors by Samy Mohamady, Mahmoud Galal, Wagdy M. Eldehna, David C. Gutierrez, Hany S. Ibrahim, Mohey M. Elmazar, Hamed I. Ali

Get full text

CM082, a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non‐small cell lung cancer in vitro and in vivo by Kun Zhang, Lili Wang, Aili Wei, Xinfei Jia, Xiaoqing Liu

Subjects: “…Angiogenesis inhibitor…”
Get full text

First‐line immunotherapy or angiogenesis inhibitor combined with chemotherapy for advanced non‐small cell lung cancer with EGFR exon 20 insertions: Real‐world evidence from China by Guangjian Yang, Yaning Yang, Runze Liu, Weihua Li, Haiyan Xu, Xuezhi Hao, Junling Li, Shuyang Zhang, Fei Xu, Siyu Lei, Yan Wang

Subjects: “…angiogenesis inhibitor…”
Get full text

Efficacy and safety of EGFR-TKIs in combination with angiogenesis inhibitors as first-line therapy for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and meta-analysis by Di Hu, Yan-Yan Zhou, Hong-Bo Ma, Miao-Miao Tao, Qun-Zhen Huang, Zhen-Zhou Yang, Qi Zhou

Subjects: Get full text

Inhibition of Pathological Retinal Neovascularization by a Small Peptide Derived from Human Tissue-Type Plasminogen Kringle 2 by Qian Sun, Qian Sun, Qian Sun, Yinchen Shen, Yinchen Shen, Yinchen Shen, Li Su, Li Su, Li Su, Xun Xu, Xun Xu, Xun Xu

Subjects: Get full text

Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophago... by Naoki Takahashi, Hiroki Hara, Kengo Nagashima, Kenro Hirata, Toshiki Masuishi, Toshihiko Matsumoto, Hisato Kawakami, Kentaro Yamazaki, Shuichi Hironaka, Narikazu Boku, Kei Muro

Subjects: Get full text

Efficacy and safety of low‐dose apatinib in ovarian cancer patients with platinum‐resistance or platinum‐refractoriness: A single‐center retrospective study by Wei Chen, Ziting Li, Zhong Zheng, Xiaohua Wu

Subjects: “…angiogenesis inhibitor…”
Get full text

Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer by Zhongmian Pan, Zhongbin Luo, Hongying He, Yujie Chen, Bingbing Zhao, Zhijun Yang, Li Li

Subjects: Get full text

On-Target Side Effects of Targeted Therapeutics of Cancer by József Tímár, Andrea Uhlyarik

Subjects: Get full text

Canonical NF-κB signaling maintains corneal epithelial integrity and prevents corneal aging via retinoic acid by Qian Yu, Soma Biswas, Gang Ma, Peiquan Zhao, Baojie Li, Jing Li

Subjects: “…angiogenesis inhibitor…”
Get full text

Anti-Vascular Endothelial Growth Factor (Bevacizumab) Therapy Reduces Hypertrophic Scar Formation in a Rabbit Ear Wounding Model by Do Hoon Kwak, Tae Hui Bae, Woo Seob Kim, Han Koo Kim

Subjects: Get full text

Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer by Yu-Sen Huang, Jenny Ling-Yu Chen, Hsin-Ming Chen, Li-Hao Yeh, Jin-Yuan Shih, Ruoh-Fang Yen, Yeun-Chung Chang

Subjects: Get full text

Genetic association with intravitreal ranibizumab response for neovascular age-related macular degeneration in Hispanic population by Francisco Jose Rodriguez, Hernan Andres Rios, María Camila Aguilar, Shirley Margarita Rosenstiehl, Nancy Gelvez, Greizy Lopez, Martha L Tamayo

Subjects: “…angiogenesis inhibitors…”
Get full text

Combined Therapy against Recurrent Hemangiopericytoma: A Case Report by Xiao-dong Li, Jing-ting Jiang, Chang-ping Wu

Subjects: Get full text

Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth by Brian C. Stagg, Hironori Uehara, Nathan Lambert, Ruju Rai, Isha Gupta, Bryce Radmall, Taylor Bates, Balamurali K. Ambati

Subjects: “…VEGFR2, angiogenesis inhibitors, morpholinos, alternative polyadenylation…”
Get full text

Comparison of three rapamycin dosing schedules in A/J <it>Tsc2</it>^+/-mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors by Dabora Sandra L, Nobil Alison, Woodrum Chelsey

“…In the <it>Tsc2</it>^-/-subcutaneous tumor mouse model, vincristine is not effective, but angiogenesis inhibitors (sunitinib and bevacizumab) and asparaginase are effective as single agents. …”
Get full text

Surgical Conversion for Initially Unresectable Locally Advanced Hepatocellular Carcinoma Using a Triple Combination of Angiogenesis Inhibitors, Anti-PD-1 Antibodies, and Hepatic Arterial Infusion Chemotherapy: A Retrospective Study by Jinliang Zhang, Xihao Zhang, Han Mu, Ge Yu, Wenge Xing, Lu Wang, Lu Wang, Ti Zhang, Ti Zhang, Ti Zhang

“…Toxic side effects were manageable.ConclusionA triple combination therapy regimen of angiogenesis inhibitors, programmed death-1 inhibitors and hepatic arterial infusion chemotherapy showed significant therapeutic effect with an extremely high surgical conversion rate in patients with initially unresectable HCC.…”
Get full text

Quinazoline derivative compound (11d) as a novel angiogenesis inhibitor inhibiting VEGFR2 and blocking VEGFR2-mediated Akt/mTOR /p70s6k signaling pathway by Zeng Li, Bin Wang, Liang Tang, Shuangsheng Chen, Jun Li

Get full text

Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs by Pierre Decazes, Samy Ammari, Antoine De Prévia, Léo Mottay, Littisha Lawrance, Younes Belkouchi, Baya Benatsou, Laurence Albiges, Corinne Balleyguier, Pierre Vera, Nathalie Lassau

Subjects: Get full text